[Lung transplantation for secondary interstitial pneumonitis caused by treatment for primary mediastinal diffuse large B-cell lymphoma].

Mitsutomo Kohno, Naoki Hasegawa, Shinichiro Okamoto, Takashi Kondo, Hiroaki Nomori

Research output: Contribution to journalArticle

Abstract

A 34-year-old woman was diagnosed as primary mediastinal diffuse large B-cell lymphoma, treated by cyclophosphamide, doxorubicin, vincrisitne, prednisolone (CHOP) chemotherapy and radiation therapy, and received high-dose ranimustine, cytarabine, etoposide, cyclophosphamide (MCVAC) chemotherapy with autologous peripheral blood stem cell transplantation. Seven years after complete remission was achieved, she recognized dyspnea and was diagnosed secondary interstitial pneumonitis caused by chemotherapy and/or radiotherapy. Because her symptoms and pulmonary function got worsen gradually, she underwent lung transplantation from a brain death donor when she was 47-year-old. She has successfully rehabilitated and returned to her life without oxygen inhalation therapy.

Original languageEnglish
Pages (from-to)1119-1121
Number of pages3
JournalKyobu geka. The Japanese journal of thoracic surgery
Volume63
Issue number13
Publication statusPublished - 2010 Dec
Externally publishedYes

Fingerprint

Lung Transplantation
Lymphoma, Large B-Cell, Diffuse
Interstitial Lung Diseases
Drug Therapy
Cyclophosphamide
Oxygen Inhalation Therapy
Radiotherapy
Peripheral Blood Stem Cell Transplantation
Brain Death
Cytarabine
Etoposide
Prednisolone
Dyspnea
Doxorubicin
Therapeutics
Tissue Donors
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

[Lung transplantation for secondary interstitial pneumonitis caused by treatment for primary mediastinal diffuse large B-cell lymphoma]. / Kohno, Mitsutomo; Hasegawa, Naoki; Okamoto, Shinichiro; Kondo, Takashi; Nomori, Hiroaki.

In: Kyobu geka. The Japanese journal of thoracic surgery, Vol. 63, No. 13, 12.2010, p. 1119-1121.

Research output: Contribution to journalArticle

@article{7a9576b13b8a4409a29156c27c3eb0a7,
title = "[Lung transplantation for secondary interstitial pneumonitis caused by treatment for primary mediastinal diffuse large B-cell lymphoma].",
abstract = "A 34-year-old woman was diagnosed as primary mediastinal diffuse large B-cell lymphoma, treated by cyclophosphamide, doxorubicin, vincrisitne, prednisolone (CHOP) chemotherapy and radiation therapy, and received high-dose ranimustine, cytarabine, etoposide, cyclophosphamide (MCVAC) chemotherapy with autologous peripheral blood stem cell transplantation. Seven years after complete remission was achieved, she recognized dyspnea and was diagnosed secondary interstitial pneumonitis caused by chemotherapy and/or radiotherapy. Because her symptoms and pulmonary function got worsen gradually, she underwent lung transplantation from a brain death donor when she was 47-year-old. She has successfully rehabilitated and returned to her life without oxygen inhalation therapy.",
author = "Mitsutomo Kohno and Naoki Hasegawa and Shinichiro Okamoto and Takashi Kondo and Hiroaki Nomori",
year = "2010",
month = "12",
language = "English",
volume = "63",
pages = "1119--1121",
journal = "Japanese Journal of Thoracic Surgery",
issn = "0021-5252",
publisher = "Nankodo Co., Ltd.",
number = "13",

}

TY - JOUR

T1 - [Lung transplantation for secondary interstitial pneumonitis caused by treatment for primary mediastinal diffuse large B-cell lymphoma].

AU - Kohno, Mitsutomo

AU - Hasegawa, Naoki

AU - Okamoto, Shinichiro

AU - Kondo, Takashi

AU - Nomori, Hiroaki

PY - 2010/12

Y1 - 2010/12

N2 - A 34-year-old woman was diagnosed as primary mediastinal diffuse large B-cell lymphoma, treated by cyclophosphamide, doxorubicin, vincrisitne, prednisolone (CHOP) chemotherapy and radiation therapy, and received high-dose ranimustine, cytarabine, etoposide, cyclophosphamide (MCVAC) chemotherapy with autologous peripheral blood stem cell transplantation. Seven years after complete remission was achieved, she recognized dyspnea and was diagnosed secondary interstitial pneumonitis caused by chemotherapy and/or radiotherapy. Because her symptoms and pulmonary function got worsen gradually, she underwent lung transplantation from a brain death donor when she was 47-year-old. She has successfully rehabilitated and returned to her life without oxygen inhalation therapy.

AB - A 34-year-old woman was diagnosed as primary mediastinal diffuse large B-cell lymphoma, treated by cyclophosphamide, doxorubicin, vincrisitne, prednisolone (CHOP) chemotherapy and radiation therapy, and received high-dose ranimustine, cytarabine, etoposide, cyclophosphamide (MCVAC) chemotherapy with autologous peripheral blood stem cell transplantation. Seven years after complete remission was achieved, she recognized dyspnea and was diagnosed secondary interstitial pneumonitis caused by chemotherapy and/or radiotherapy. Because her symptoms and pulmonary function got worsen gradually, she underwent lung transplantation from a brain death donor when she was 47-year-old. She has successfully rehabilitated and returned to her life without oxygen inhalation therapy.

UR - http://www.scopus.com/inward/record.url?scp=79952201236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952201236&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 1119

EP - 1121

JO - Japanese Journal of Thoracic Surgery

JF - Japanese Journal of Thoracic Surgery

SN - 0021-5252

IS - 13

ER -